Orlistat Pellets (CAS No: 96829-58-2) — Pharmaceutical Multiparticulates
Orlistat Pellets are pharmaceutical pellets manufactured from Orlistat (C₂₉H₅₃NO₅, MW ≈495.7), a gastrointestinal/pancreatic lipase inhibitor used in weight-management formulations. The drug substance is a white to almost-white powder or crystalline solid with a melting point of 43°C–47°C, is insoluble in water, and is soluble in chloroform and readily soluble in ethanol — properties that make particle-size control and moisture protection especially important during pellet manufacture. Swapnroop Drugs and Pharmaceuticals manufactures Orlistat Pellets at its WHO-GMP certified Aurangabad, Maharashtra facility for pharmaceutical formulators across India and export markets.
Formulation Approach
Given Orlistat's low melting point (43–47°C) and water-insolubility, pellet manufacturing typically involves controlled-temperature processing (drug-layering or granulation) to avoid softening/agglomeration of the API during coating, along with lipophilic-drug-appropriate dissolution-enhancement strategies where needed.
Key Features
Applications
Why Choose Swapnroop for Orlistat Pellets?
FAQs
| Parameter | Specification |
|---|---|
| Appearance | white to off-white crystalline powder |
| Identification | IR & HPLC compliant |
| Assay (HPLC) | 98.0% – 102.0% |
| Loss on Drying | NMT 2.0% |
| Residue on Ignition | NMT 0.5% |
| Heavy Metals | NMT 10 ppm |
| Individual Impurity | NMT 0.5% |
| Total Impurities | NMT 1.0% |
| Water Content | NMT 2.0% |